Owners, management and financials
CVR: 45009092
Secondary names: C2N Diagnostics Denmark ApS, C2N EU ApS
DKK -129,956
Gross profit
Net result: DKK -140,078
C2N Global, Inc (100%)
CVR · view owners
Dr. Joel B. Braunstein
CVR · view management
Active
Founded 9 August 2024
CVR · view overview
1 employee
Annual report 2025 · average
Name registered: C2N Diagnostics EU ApS
CVR · 09/08/2024
View the full event history
C2N Diagnostics EU ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dr. Joel B. Braunstein. The company is owned by C2N Global, Inc. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -129,956 and a net result of DKK -140,078. Equity in the 2025 report amounted to DKK -202,154.
Selskabets formål er at engagere sig i følgende forretningsaktiviteter: 1) Forskning og udvikling samt fremstilling af diagnostiske og terapeutiske produkter; 2) Engroshandel og detailhandel med diagnostiske og terapeutiske produkter; 3) Import, eksport, markedsføring og eftersalgsservice af diagnostiske og terapeutiske produkter; og hermed beslægtet virksomhed efter direktions skøn.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -130 t. | -140 t. | 40 t. | -202 t. | 1 |
Compared to 1.038 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of C2N Diagnostics EU ApS is 45009092.
C2N Diagnostics EU ApS is owned by C2N Global, Inc.
The management of C2N Diagnostics EU ApS consists of Dr. Joel B. Braunstein.
In 2025, C2N Diagnostics EU ApS reported a gross profit of DKK -129,956.
C2N Diagnostics EU ApS had an average of 1 employee in the 2025 financial year according to the annual report.
C2N Diagnostics EU ApS was founded on 9 August 2024.
Claim this page to add your logo and social links. Free to get started.
C2N Diagnostics EU ApS has published its annual report for 2025. Gross profit came to DKK -129,956, and the net result was DKK -140,078.
C2N Diagnostics EU ApS has published its interim report for the period August 9, 2024 to December 31, 2024.
As of August 9, 2024, Dr. Joel B. Braunstein is registered as director of C2N Diagnostics EU ApS.
As of August 9, 2024, is registered as an owner of C2N Diagnostics EU ApS with an ownership share of 100%.
C2N Diagnostics EU ApS was founded on August 9, 2024.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 29418888
CVR 29769796
CVR 34688605
CVR 34892970
CVR 35047565
